Latest Tax Incentives News

Actinogen Medical has fast-tracked enrolment in its pivotal Alzheimer’s trial, secured a clear FDA regulatory path, and strengthened its financial position with funding extending its runway to mid-2026.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

PMET Resources has completed a positive lithium-only feasibility study for its Shaakichiuwaanaan Project in Quebec, confirming technical and economic viability for a large-scale spodumene concentrate operation with a targeted final investment decision in 2027.

Advanced Braking Technology Ltd has kicked off FY26 with a 21% rise in product sales revenue and a 66% jump in net profit before tax, underpinned by expanding international demand and progress in autonomous braking systems.

Chalice Mining is progressing its Gonneville Project Pre-Feasibility Study on schedule for November 2025 completion, fully funded and targeting a Final Investment Decision by late 2027 as palladium prices hit a two-year high.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

FortifAI Limited reported steady revenue and significant cost reductions in Q1 FY26, while securing new contracts and advancing AI initiatives to boost operational efficiency.

Hazer Group has received a $4.58 million R&D tax incentive refund for FY25, reinforcing its financial position as it advances its methane pyrolysis technology towards commercialisation.

Great Dirt Resources reports promising lithium soil anomalies in Western Australia's Pilbara region and progresses manganese exploration in New South Wales, supported by a solid cash position of $2.4 million.

SenSen Networks reported a record first quarter for FY26 with $4.3 million in cash receipts and positive operating cashflow, driven by new contracts across Singapore, the USA, and Australia. The company’s AI platform SenDISA continues to expand its footprint in Smart City solutions.